Concentration Risk in Portfolios and the Top 10

Concentration Risk in Portfolios Over Seven Decades

Concentration risk in portfolios is the risk that a small number of positions drive most of your results. Right now it is one of the most underappreciated exposures in US equities, because it hides inside the index that most investors treat as safe and diversified. Owning the S&P 500 today means placing an outsized bet on a handful of mega-cap names.

The long-run evidence is worth sitting with. Research from GMO, the firm co-founded by Jeremy Grantham, shows that since 1957 the ten largest stocks in the S&P 500 have underperformed an equal-weighted index of the remaining 490 by about 2.4% per year. Being in the biggest names, across almost seven decades, was the losing side of the trade.

[Inline exhibit placement: GMO chart "S&P 500 – Top 10 vs 490 Equal Weighted", data 1957 to 2023. Alt text: Chart of S&P 500 top 10 stocks versus the equal-weighted 490, showing decades of relative decline and a sharp reversal after 2013. Caption: The relative line fell for decades, then reversed sharply from 2013. Source: GMO; Compustat; Standard & Poor's.]

Why the Biggest Names Tend to Lag

The reason is logical rather than mysterious. By the time a company reaches the top ten, it has usually already delivered years of exceptional growth. Expectations are high, the good news is largely priced in, and the base is now enormous. Sustaining the same pace from there is far harder than it was on the way up.

Academics call this mean reversion. What rises to an extreme tends to normalise over time. The 2.4% annual gap is not a quirk of one era. It is the average outcome across bull markets, recessions and everything in between.

A practical read for a trader: treating the current leaders as a permanent core holding assumes they will keep defying a pattern that has held for close to seventy years.

The Last Decade Broke the Pattern

Here is the complication. Since 2013 the script has flipped. The ten largest stocks have outperformed the other 490 by roughly 4.9% per year, a reversal with no precedent in the full series. The dominance of a small group of mega-cap technology names has been, on the data, almost unparalleled.

That leaves two possibilities, and it is worth being honest that nobody knows which holds. Either these companies are genuinely a new kind of business that compounds at a scale never seen before, or the historical pattern eventually reasserts itself and heavily concentrated portfolios face a painful adjustment. A disciplined process does not need to pick a winner between those. It needs to be positioned so that either outcome is survivable.

From Index Bet to Deliberate Book

This is where concentration becomes a choice rather than an accident. Buying a cap-weighted index feels diversified, yet it quietly loads the portfolio into whatever is already largest and most expensive. The equal-weighted version of the same 500 companies is a useful mirror. When it lags badly, leadership is narrow and concentration risk is high.

The ImGeld process addresses this by working from Market to Industry to Stock rather than defaulting to the mega-cap layer. Leadership is assessed at the industry level, and individual names are chosen on relative strength within strong industries, not on sheer size. That keeps a book anchored to genuine participation instead of a handful of dominant tickers.

For execution, an equity trader can track the gap between the cap-weighted and equal-weighted index as an ongoing concentration gauge, and cap single-name and single-theme exposure regardless of how strong the leaders look.

The Behavioural Pull Toward the Giants

The hardest part is emotional. When the largest names lead for years, staying diversified feels like a mistake, and every quarter of underperformance tempts an investor to give up and crowd into the winners. That instinct peaks precisely when concentration risk is greatest.

The opposite error also exists. Refusing to hold leaders at all, purely on valuation, has been costly through this cycle. The answer is not a prediction about when the pattern breaks. It is a rule set that limits how much any one name or theme can dominate the outcome.

Key Takeaway

• Concentration risk in portfolios is often hidden inside cap-weighted index exposure, not just in obvious single-stock bets.
• Since 1957 the ten largest S&P 500 stocks have lagged the equal-weighted 490 by about 2.4% per year, as dominance tends to mean-revert.
• Since 2013 that pattern reversed to roughly plus 4.9% per year, an unprecedented run that may or may not persist.
• A Market to Industry to Stock process manages the risk by anchoring to industry leadership and relative strength rather than size.

Conclusion

Concentration risk in portfolios rewards patience with information. Seventy years of data suggest that being permanently overweight the biggest names is a poor long-run bet, while the last decade is a stark reminder that patterns can invert for years at a time. Neither fact is a forecast. Together they argue for a process that respects leadership without surrendering to it, sizes risk deliberately, and keeps the average stock in view. That is a more durable stance than betting everything on the giants staying magnificent.

FAQ

What is concentration risk in a portfolio?

It is the risk that a small number of holdings, or a single theme, drive most of the portfolio's returns and losses. It can come from obvious single-stock bets or, less visibly, from owning a cap-weighted index dominated by a few mega-caps.

Do the largest stocks really underperform over time?

On long horizons, historically yes. GMO's data shows the ten largest S&P 500 stocks trailed the equal-weighted remaining 490 by about 2.4% per year since 1957, though the past decade has been a sharp exception with the leaders well ahead.

Why do dominant companies tend to lag later?

By the time a company is among the largest, its strong growth is usually well known and priced in, and its size makes repeating that growth harder. Returns of dominant companies tend to fade toward the average over time.

Is an equal-weight index safer than a cap-weighted one?

It is not automatically safer, but it carries less single-name concentration and gives every company the same weight. Comparing the two is a useful way to see whether current leadership is broad or narrow.

How can a trader manage concentration risk in practice?

By capping how much any one stock or theme can influence the book, watching the cap-weight versus equal-weight gap, and selecting names on industry strength and relative strength rather than size alone.